These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 29371911)

  • 21. WNT5A-ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3.
    Arabzadeh S; Hossein G; Salehi-Dulabi Z; Zarnani AH
    Cell Mol Biol Lett; 2016; 21():9. PubMed ID: 28536612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ; Jelovac D; Thiantanawat A; Brodie AM
    Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stage of breast cancer progression influences cellular response to activation of the WNT/planar cell polarity pathway.
    MacMillan CD; Leong HS; Dales DW; Robertson AE; Lewis JD; Chambers AF; Tuck AB
    Sci Rep; 2014 Sep; 4():6315. PubMed ID: 25204426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of toll-like receptors on breast tumors: taking a toll on tumor microenvironment.
    Bhattacharya D; Yusuf N
    Int J Breast Cancer; 2012; 2012():716564. PubMed ID: 22295250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stat3 mediates expression of autotaxin in breast cancer.
    Azare J; Doane A; Leslie K; Chang Q; Berishaj M; Nnoli J; Mark K; Al-Ahmadie H; Gerald W; Hassimi M; Viale A; Stracke M; Lyden D; Bromberg J
    PLoS One; 2011; 6(11):e27851. PubMed ID: 22140473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenylmethimazole inhibits production of proinflammatory mediators and is protective in an experimental model of endotoxic shock*.
    Benavides U; Gonzalez-Murguiondo M; Harii N; Lewis CJ; Schwartz AL; Giuliani C; Napolitano G; Dagia NM; Malgor R; McCall KD; Kohn LD
    Crit Care Med; 2012 Mar; 40(3):886-94. PubMed ID: 22020240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer.
    Salaun B; Zitvogel L; Asselin-Paturel C; Morel Y; Chemin K; Dubois C; Massacrier C; Conforti R; Chenard MP; Sabourin JC; Goubar A; Lebecque S; Pierres M; Rimoldi D; Romero P; Andre F
    Cancer Res; 2011 Mar; 71(5):1607-14. PubMed ID: 21343393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenylmethimazole blocks palmitate-mediated induction of inflammatory cytokine pathways in 3T3L1 adipocytes and RAW 264.7 macrophages.
    McCall KD; Holliday D; Dickerson E; Wallace B; Schwartz AL; Schwartz C; Lewis CJ; Kohn LD; Schwartz FL
    J Endocrinol; 2010 Dec; 207(3):343-53. PubMed ID: 20813836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.
    Lin L; Hutzen B; Zuo M; Ball S; Deangelis S; Foust E; Pandit B; Ihnat MA; Shenoy SS; Kulp S; Li PK; Li C; Fuchs J; Lin J
    Cancer Res; 2010 Mar; 70(6):2445-54. PubMed ID: 20215512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer.
    Grivennikov SI; Karin M
    Cytokine Growth Factor Rev; 2010 Feb; 21(1):11-9. PubMed ID: 20018552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells.
    Gakhar G; Hua DH; Nguyen TA
    Anticancer Drugs; 2010 Jan; 21(1):77-88. PubMed ID: 19966541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STATs in cancer inflammation and immunity: a leading role for STAT3.
    Yu H; Pardoll D; Jove R
    Nat Rev Cancer; 2009 Nov; 9(11):798-809. PubMed ID: 19851315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment.
    Sato Y; Goto Y; Narita N; Hoon DS
    Cancer Microenviron; 2009 Sep; 2 Suppl 1(Suppl 1):205-14. PubMed ID: 19685283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The opposing roles of Wnt-5a in cancer.
    McDonald SL; Silver A
    Br J Cancer; 2009 Jul; 101(2):209-14. PubMed ID: 19603030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.
    Schwartz AL; Malgor R; Dickerson E; Weeraratna AT; Slominski A; Wortsman J; Harii N; Kohn AD; Moon RT; Schwartz FL; Goetz DJ; Kohn LD; McCall KD
    Clin Cancer Res; 2009 Jun; 15(12):4114-22. PubMed ID: 19470740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toll-like receptors in inflammation, infection and cancer.
    Chen K; Huang J; Gong W; Iribarren P; Dunlop NM; Wang JM
    Int Immunopharmacol; 2007 Oct; 7(10):1271-85. PubMed ID: 17673142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High basal levels of functional toll-like receptor 3 (TLR3) and noncanonical Wnt5a are expressed in papillary thyroid cancer and are coordinately decreased by phenylmethimazole together with cell proliferation and migration.
    McCall KD; Harii N; Lewis CJ; Malgor R; Kim WB; Saji M; Kohn AD; Moon RT; Kohn LD
    Endocrinology; 2007 Sep; 148(9):4226-37. PubMed ID: 17525119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis and cancer (Review).
    Katoh M; Katoh M
    Int J Mol Med; 2007 Feb; 19(2):273-8. PubMed ID: 17203201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion.
    Kurayoshi M; Oue N; Yamamoto H; Kishida M; Inoue A; Asahara T; Yasui W; Kikuchi A
    Cancer Res; 2006 Nov; 66(21):10439-48. PubMed ID: 17079465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammation, a key event in cancer development.
    Lu H; Ouyang W; Huang C
    Mol Cancer Res; 2006 Apr; 4(4):221-33. PubMed ID: 16603636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.